{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:47:28Z","timestamp":1781459248372,"version":"3.54.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research","award":["23925032"],"award-info":[{"award-number":["23925032"]}]},{"name":"Grant-in-Aid for Scientific Research","award":["15H04601"],"award-info":[{"award-number":["15H04601"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.vetimm.2017.05.004","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T16:30:18Z","timestamp":1494693018000},"page":"84-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Identification of a secondary mutation in the KIT kinase domain correlated with imatinib-resistance in a canine mast cell tumor"],"prefix":"10.1016","volume":"188","author":[{"given":"Yuko","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Bonkobara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamine","family":"Takanosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2017.05.004_bib0005","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/1078-0432.CCR-04-2245","article-title":"Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation","volume":"11","author":"Antonescu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0010","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0015","doi-asserted-by":"crossref","first-page":"E2276","DOI":"10.1073\/pnas.1115240109","article-title":"Imatinib resistance and microcytic erythrocytosis in a KitV558Delta;T669I\/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor","volume":"109","author":"Bosbach","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0020","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1158\/0008-5472.CAN-04-0085","article-title":"A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors","volume":"64","author":"Chen","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0025","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0035","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2013advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"New Engl. J Med."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1746-6148-10-105","article-title":"Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia\u00ae) in canine mast cell tumor","volume":"10","author":"Halsey","year":"2014","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0045","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1200\/JCO.2006.06.2265","article-title":"Molecular correlates of imatinib resistance in gastrointestinal stromal tumors","volume":"24","author":"Heinrich","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1939-1676.2008.00132.x","article-title":"Effect of tyrosine kinase inhibition by imatinib mesylate on mast cell tumors in dogs","volume":"22","author":"Isotani","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1365-2141.2009.07926.x","article-title":"Mutations in the fifth immunoglobulin-like domain of kit are common and potentially sensitive to imatinib mesylate in feline mast cell tumours","volume":"148","author":"Isotani","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0060","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tvjl.2011.10.027","article-title":"Canine intestinal mast cell tumor with c-kit exon 8 mutation responsive to imatinib therapy","volume":"193","author":"Kobayashi","year":"2012","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/ejh.12526","article-title":"Molecular changes associated with the development of resistance to imatinib in an imatinib-sensitive canine neoplastic mast cell line carrying a KIT c.1523A>T mutation","volume":"95","author":"Kobayashi","year":"2015","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0070","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1158\/1541-7786.MCR-08-0067","article-title":"Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors","volume":"6","author":"Letard","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0075","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1038\/sj.onc.1210173","article-title":"A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors","volume":"26","author":"Mahadevan","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.vetimm.2017.05.004_bib0080","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1292\/jvms.13-0156","article-title":"Imatinib responsiveness in canine mast cell tumors carrying novel mutations of c-KIT exon 11","volume":"76","author":"Nakano","year":"2014","journal-title":"J. Vet. Med. Sci."},{"issue":"3","key":"10.1016\/j.vetimm.2017.05.004_bib0085","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/jnci\/djn477","article-title":"T670X KIT mutations in gastrointestinal stromal tumors: making sense of missense","volume":"101","author":"Negri","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1349-7006.2008.00727.x","article-title":"Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor","volume":"99","author":"Nishida","year":"2008","journal-title":"Cancer Sci."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0095","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(07)60780-6","article-title":"Gastrointestinal stromal tumour","volume":"369","author":"Rubin","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vetimm.2017.05.004_bib0100","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tvjl.2015.10.051","article-title":"Analysis of c-KIT exon 11 mutations in canine gastrointestinal stromal tumours","volume":"207","author":"Takanosu","year":"2016","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0105","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/sj.onc.1209639","article-title":"Functional analyses and molecular modeling of two c-Kit mutations responsible for imatinib secondary resistance in GIST patients","volume":"25","author":"Tamborini","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.vetimm.2017.05.004_bib0110","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1158\/1078-0432.CCR-05-0710","article-title":"Multidrug resistance proteins in gastrointestinal stromal tumors: site-dependent expression and initial response to imatinib","volume":"11","author":"Theou","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0115","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-4-7","article-title":"A single-tube allele specific-polymerase chain reaction to detect T315I resistant mutation in chronic myeloid leukemia patients","volume":"4","author":"Wongboonma","year":"2011","journal-title":"J. Hematol Oncol."},{"key":"10.1016\/j.vetimm.2017.05.004_bib0120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.vetimm.2011.04.002","article-title":"Imatinib elicited a favorable response in a dog with a mast cell tumor carrying a c-kit c.1523A>T mutation via suppression of constitutive KIT activation","volume":"142","author":"Yamada","year":"2011","journal-title":"Vet. Immunol. Immunopathol."}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717301046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242717301046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T16:49:03Z","timestamp":1602089343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242717301046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":24,"alternative-id":["S0165242717301046"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2017.05.004","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a secondary mutation in the KIT kinase domain correlated with imatinib-resistance in a canine mast cell tumor","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2017.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}